Home / Health / Is India Using the COVID Vaccine Strategy Wrong? News about the coronavirus outbreak

Is India Using the COVID Vaccine Strategy Wrong? News about the coronavirus outbreak



India has exported millions of COVID-19 vaccines, despite record numbers of cases and deaths in recent weeks.

On Saturday, India announced it would vaccinate anyone over the age of 18 to cover some 600 million people as the country struggles to cope with the second coronavirus that swept the nation’s most populous nation. Second world

But few vaccines can vaccinate people, with experts criticizing the government’s lack of readiness to fight the virus that killed nearly 40,000 people in April alone. More than 20 million Indians are now infected as daily infection rates continue to break records.

Public outrage has escalated to Prime Minister Narendra Modi̵

7;s government for dealing with India’s worst health crisis since independence in 1947.

(Al Jazeera)

Experts say the health infrastructure has suffered as the number of cases increases amid the slow launch of a vaccination campaign. Modi’s government has also been criticized for allowing Hindu religious festivals and electoral campaigns to continue, an event that turned out to be a “fast-paced”.

Vaccination is one of the biggest weapons against the rising virus. But according to Our World in Data as of May 2, only 2 percent of India’s 1.4 billion people were fully vaccinated the first and second time, and nearly 9.2 percent of the population received the drug. At least once

Bloomberg News reports that the government has not ordered the larger than 110 million doses of the vaccine from the Serum Institute of India (SII), the world’s largest vaccine maker, has been based in Pune since. It started selling in December, which is hardly enough for 4 percent of the population.

SII, which produces the vaccine Oxford-AstraZeneca Was asked by the Indian government to halt all exports, which affects the global vaccine supply.

India has also approved a vaccine against kovacin made by India’s Bharat Biotech.

Last month, the government followed up with emergency approval for the COVID-19 vaccine from Russia’s Pfizer-BioNTech, Johnson & Johnson, Novavax, Moderna and Sputnik V. last month.

More than 13 million people aged 18-44 have signed up for the vaccine. But states, including Madhya Pradesh and the heavily hit state of Maharashtra, have been able to vaccinate a very small population amid drug shortages.

Between January and April, India exported 11 million doses, one of the 66 million vaccines distributed worldwide as part of the Vaccine Ambassador Program.

India’s push for vaccination has also been political after the federal government asked the state government to provide the vaccine.

Public health experts and opposition leaders have urged the federal government to run immunization programs rather than assign them to the state government.




Source link